Liming Xie

Hengyang, 421001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

A high-efficiency automatic pressure-relief drug transfer device for anticancer medications with superior closed performance.

A high-efficiency automatic pressure-relief drug transfer device for anticancer medications with superior closed performance.

Journal: Frontiers in pharmacology

Published: February 19, 2025

Efficacy of Pyrotinib combined with Trastuzumab in the treatment of patients with human epidermal growth factor receptor-2 positive breast cancer.

Efficacy of Pyrotinib combined with Trastuzumab in the treatment of patients with human epidermal growth factor receptor-2 positive breast cancer.

Journal: Pakistan journal of medical sciences

Published: December 16, 2024

Kinesin family member 4 a drives Cancer stem cell characteristics in breast Cancer: Insights from scRNA-Seq and experimental validation.

Kinesin family member 4 a drives Cancer stem cell characteristics in breast Cancer: Insights from scRNA-Seq and experimental validation.

Journal: International journal of biological macromolecules

Published: August 23, 2024

Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer.

Discovery of novel small molecules targeting the USP21/JAK2/STAT3 axis for the treatment of triple-negative breast cancer.

Journal: European journal of medicinal chemistry

Published: March 12, 2024

SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics.

SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics.

Journal: Cell biology and toxicology

Published: January 23, 2024

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.

SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.

Journal: Frontiers in immunology

Published: January 13, 2024

Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.

Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer.

Journal: Clinical breast cancer

Published: November 27, 2023

A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.

A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.

Journal: Cancer letters

Published: August 22, 2023

Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.

Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.

Journal: Environmental research

Published: August 02, 2023

Astragalus polysaccharide protects against blood-brain barrier damage in MCAO rats by inhibiting P2X7R channel

Astragalus polysaccharide protects against blood-brain barrier damage in MCAO rats by inhibiting P2X7R channel

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: December 12, 2022

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.

Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.

Journal: Frontiers in immunology

Published: September 06, 2022

Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.

Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.

Journal: Disease markers

Published: May 25, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026